On or around 20 January 1983, Barré-Sinoussi detects reverse transcriptase activity in cultured cells — the first sign of the virus later identified as HIV.
By approximately 20 January 1983, Françoise Barré-Sinoussi detected the first tangible evidence of a retrovirus in the lymph node cell cultures from the at-risk AIDS patient. This evidence came in the form of reverse transcriptase activity — an enzymatic signature unique to retroviruses, which use this enzyme to convert their RNA genome into DNA within host cells.
This moment is widely regarded as the critical turning point in the discovery of the virus that causes AIDS. It was the first hard, reproducible laboratory signal that a new retrovirus was present and replicating in the patient's cells, distinguishing it from previously known human retroviruses such as HTLV. Barré-Sinoussi's technical mastery of reverse transcriptase assays — developed over years of prior training — was essential to correctly interpreting this signal amid considerable scientific uncertainty and skepticism.
This discovery set in motion the subsequent steps of visual confirmation via electron microscopy and full viral characterization, culminating in the landmark May 1983 Science publication. It stands as a genuine scientific first: the earliest documented detection of what would become known as the Human Immunodeficiency Virus (HIV), fundamentally altering the trajectory of global public health and biomedical research for decades to come.